United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - ramipril - oral capsule - 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - ramipril - oral capsule - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

genesis pharmaceuticals ltd - omeprazole - gastro-resistant capsule - 40mg

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - nizatidine, quantity: 300 mg - capsule - excipient ingredients: croscarmellose sodium; iron oxide yellow; magnesium stearate; colloidal anhydrous silica; gelatin; sodium lauryl sulfate; purified talc; titanium dioxide; pregelatinised maize starch; iron oxide red; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - tacidine is indicated for up to 8 weeks for the treatment of active duodenal ulcer. in most patients, the ulcer will heal within 4 weeks. tacidine is also indicated for the maintenance therapy for duodenal ulcer patients, at a reduced dosage of 150mg at bedtime, after healing of the active duodenal ulcer. continuous therapy with nizatidine for longer than 1 year has not been studied. tacidine is indicated for up to 8 weeks for the treatment of benign gastric ulcer. tacidine is indicated for up to 12 weeks for the treatment of oesophagitis, including erosive and ulcerative oesophagitis and associated heartburn due to reflux.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - nizatidine, quantity: 150 mg - capsule - excipient ingredients: magnesium stearate; croscarmellose sodium; gelatin; allura red ac; pregelatinised maize starch; colloidal anhydrous silica; quinoline yellow; titanium dioxide; sodium lauryl sulfate; iron oxide yellow; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - tacidine is indicated for up to 8 weeks for the treatment of active duodenal ulcer. in most patients, the ulcer will heal within 4 weeks. tacidine is also indicated for the maintenance therapy for duodenal ulcer patients, at a reduced dosage of 150mg at bedtime, after healing of the active duodenal ulcer. continuous therapy with nizatidine for longer than 1 year has not been studied. tacidine is indicated for up to 8 weeks for the treatment of benign gastric ulcer. tacidine is indicated for up to 12 weeks for the treatment of oesophagitis, including erosive and ulcerative oesophagitis and associated heartburn due to reflux.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

somex pharma - lymecycline - oral capsule - 408mg

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

muscat pharmaceutical trading oman - 15's plastic bottle - capsule - 20mg/capsule - gastrointestinal system-ulcer-healing

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

muscat pharmaceutical trading oman - 12's (3's blister x 4) - capsule - 200mg/capsule - infections-antibacterial

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

muscat pharmaceutical trading oman - 1's blister - capsule - 150mg / capsule - infections-antifungal

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

muscat pharmaceutical trading oman - 14's (7's blister x 2) - capsule - 20 mg/capsule - gastrointestinal system-ulcer-healing